What is the medical use of Monosodium gluconate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Monosodium gluconate is not directly mentioned in the provided evidence, however, calcium gluconate is mentioned as a commonly used treatment to minimize peripheral vein irritation in patients with bradycardia and cardiac conduction delay 1.

Medical Use of Calcium Gluconate

The medical use of calcium gluconate is to provide calcium supplementation, particularly in cases of calcium channel blocker overdose or beta-blocker overdose, as it helps to counteract the effects of these medications on the heart 1.

  • Calcium gluconate is used to minimize peripheral vein irritation, making it a preferred choice over calcium chloride in some cases 1.
  • The evidence suggests that calcium gluconate may have hemodynamic benefits in humans, although the results are less consistent compared to animal studies 1.
  • Adverse effects of calcium gluconate, such as hypercalcemia, are rare 1.

Comparison to Other Treatments

Other treatments mentioned in the evidence include glucagon and high-dose insulin therapy, which are used to counteract the effects of beta-blocker and calcium channel blocker overdose 1.

  • Glucagon is a vasoactive polypeptide that increases heart rate, but its effects are transient and may be associated with side effects such as nausea and vomiting 1.
  • High-dose insulin therapy has been shown to improve heart rate, hemodynamic parameters, and mortality in beta-blocker and calcium channel blocker overdose, but its evidence base is of lower quality and may be associated with side effects such as hypoglycemia and hypokalemia 1.

Recommendation

Based on the most recent and highest quality evidence, calcium gluconate is a recommended treatment for patients with bradycardia and cardiac conduction delay, particularly in cases of calcium channel blocker overdose or beta-blocker overdose, due to its ability to minimize peripheral vein irritation and provide calcium supplementation 1.

From the FDA Drug Label

1 INDICATIONS & USAGE

Calcium Gluconate Injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia.

The medical use of Monosodium gluconate is not directly mentioned in the provided drug labels. However, the labels discuss the use of Calcium Gluconate Injection for the treatment of acute symptomatic hypocalcemia. Since Monosodium gluconate is not mentioned, the answer to the question about its medical use cannot be determined from the provided information. The FDA drug label does not answer the question.

From the Research

Medical Use of Monosodium Gluconate

  • Monosodium gluconate is not directly mentioned in the provided studies, however, calcium gluconate is discussed as a treatment for hypocalcemia.
  • The medical use of calcium gluconate includes:
    • Treatment of hypocalcemia in critically ill patients 2, 3, 4
    • Prevention of hypocalcemic reactions during therapeutic plasma exchange 5
    • Treatment of various conditions such as fluoride or oxalic acid poisoning, decreased myocardial contractility, and acute allergic conditions 6
  • Calcium gluconate is preferred over calcium chloride due to its lower irritation of the vessel wall and better compatibility with other nutrients in parenteral nutrition 6

Dosage and Administration

  • The dosage of calcium gluconate varies depending on the severity of hypocalcemia, with 1-2 g used for mild hypocalcemia and 2-4 g used for moderate to severe hypocalcemia 2, 3, 4
  • Calcium gluconate is typically infused at a rate of 1 g/h in a small-volume admixture 2, 3, 4
  • The efficacy of calcium gluconate therapy can be assessed by monitoring serum ionized calcium concentrations, which should be performed at least 10 hours after completion of the infusion 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of moderate to severe acute hypocalcemia in critically ill trauma patients.

JPEN. Journal of parenteral and enteral nutrition, 2007

Research

Treatment of acute hypocalcemia in critically ill multiple-trauma patients.

JPEN. Journal of parenteral and enteral nutrition, 2005

Research

[Specifics of some calcium salts in intravenous therapy of hypocalcemia and their further use].

Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.